Doctor profile · Federal record
Dr. Mark Lehman, MD
Dermatology Physician (CMS: Dermatology) · Tulsa, OK
- NPI 1932195815
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 34 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2121 E 21St St
Tulsa, OK 741141409
(918) 749-2261
fax (918) 749-8712 - Mailing address
-
Po Box 52588
Tulsa, OK 741520588
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- May 16, 2008
- Year of graduation
- 1992 — 34 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Oklahoma #19733
- Medicaid
- OK #100157070A
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1932195815. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
9,539
Distinct HCPCS
10
Medicare allowed
$508,683
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 3,815 | 648 | $6 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 2,111 | 1,208 | $85 | |
17000 |
Destruction of precancer skin growth, 1 growth | 1,407 | 863 | $50 | |
17110 |
Destruction of skin growth, 1-14 growths | 665 | 481 | $101 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 504 | 363 | $121 | |
11102 |
Biopsy of related skin growth, first growth | 270 | 234 | $84 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 110 | 110 | $105 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 88 | 86 | $53 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 78 | 51 | $157 | |
17262 |
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | 61 | 53 | $155 |
In context: peer comparison
Among 10 peers in Tulsa Dermatology Physician, average services per provider: 240. This provider delivers 40× the peer median.Open Payments
Industry payments received
All-time total
$3,065
Transactions
148
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 27 | $600.74 | |
| Regeneron Healthcare Solutions, INC. | 10 | $241.14 | |
| E.R. Squibb & Sons, L.L.C. | 14 | $229.79 | |
| Janssen Biotech, INC. | 13 | $214.37 | |
| Novartis Pharmaceuticals Corporation | 12 | $212.18 | |
| Amgen INC. | 7 | $191.66 | |
| Lilly USA, LLC | 12 | $182.87 | |
| Sun Pharmaceutical Industries INC. | 8 | $171.60 | |
| Arcutis Biotherapeutics, INC. | 14 | $163.48 | |
| Incyte Corporation | 11 | $155.12 | |
| Dermavant Sciences, INC. | 7 | $119.37 | |
| Ucb, INC. | 1 | $111.91 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | 5 | $100.15 | |
| Leo Pharma INC. | 4 | $84.12 | |
| Mayne Pharma Commercial LLC | 3 | $69.62 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,319
Patients
760
Total drug cost
$41,043
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 292 | 179 | $3,327 |
| Ketoconazole | Generic | 153 | 78 | $3,821 |
| Hydrocortisone | Generic | 141 | 95 | $942 |
| Betamethasone Dipropionate | Generic | 139 | 70 | $7,768 |
| Metronidazole | Generic | 117 | 69 | $7,916 |
| Fluocinonide | Generic | 74 | 39 | $6,253 |
| Mometasone Furoate | Generic | 71 | 51 | $1,709 |
| Mupirocin | Generic | 70 | 52 | $719 |
| Valacyclovir (Valacyclovir Hcl) | Brand | 66 | 27 | $1,625 |
| Cephalexin | Generic | 48 | 27 | $396 |
Frequently asked questions
What is Dr. Mark Lehman's medical specialty?
Dr. Mark Lehman practices Dermatology Physician in Tulsa, OK.
Where does Dr. Mark Lehman practice?
Dr. Mark Lehman practices at 2121 E 21St St, Tulsa, OK 741141409. Office phone: 9187492261.
What is Dr. Mark Lehman's NPI?
Dr. Mark Lehman's National Provider Identifier (NPI) is 1932195815, issued by NPPES.
Does Dr. Mark Lehman accept Medicare assignment?
Yes. Dr. Mark Lehman accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mark Lehman commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.